Pharmaceutical compositions

Details for Australian Patent Application No. 2009209629 (hide)

Owner Biovail Laboratories International SRL

Inventors Xiaopin, Jin; Oberegger, Werner; Walsh, Edwin; Jackson, Graham

Agent Davies Collison Cave

Pub. Number AU-A-2009209629

PCT Pub. Number WO2009/095395

Priority 61/023,951 28.01.08 US

Filing date 28 January 2009

Wipo publication date 6 August 2009

International Classifications

A61K 9/32 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/095395 Priority application(s): WO2009/095395

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009209633-Pyrazine derivatives and their use as protein kinase inhbitors

2009209621-Use of an exothermic mixture for manufacturing a bituminous mix